Physician profile
Peter J Ret
NPI 1649535162
$2,758.38
in general payments reported to CMS, 2019-2025
19 companies · $902 in 2025
The $902 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $175 · 2023: $712 · 2024: $969 · 2025: $902.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,248 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,248.39 |
| Education | $334.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $630.44 | 2022-2025 | Tremfya, Simponi Aria, Simponi |
| Abbvie INC. | $574.66 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $384.40 | 2022-2025 | Ilumya, Winlevi, Absorica Ld |
| Dermavant Sciences, INC. | $171.28 | 2024 | Vtama |
| Novartis Pharmaceuticals Corporation | $161.06 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $159.44 | 2023-2024 | Dupixent, Libtayo |
| Genzyme Corporation | $126.32 | 2023-2025 | |
| Amgen INC. | $124.55 | 2023-2025 | Otezla, Otezla |
| Pfizer INC. | $88.65 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $63.15 | 2022-2023 | Sotyktu |
| Botanix Sb INC | $38.88 | 2025 | Sofdra |
| Kyowa Kirin, INC. | $38.42 | 2023-2025 | Poteligeo |
| Ucb, INC. | $30.52 | 2025 | Bimzelx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.16 | 2023 | Cyltezo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $23.48 | 2023 | Taltz, Olumiant |
| Leo Pharma INC. | $22.79 | 2023 | Adbry |
| Strata Skin Sciences, INC. | $14.40 | 2025 | Xtrac |
| Organon LLC | $4.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Ret listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.